Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Discovery Platform
Sponsor : Versant Ventures
Deal Size : $62.0 million
Deal Type : Series A Financing
Light Horse Therapeutics Debuts with $62 Million Series A Financing
Details : The financing is intended to support the company’s discovery platform for small-molecule drug research, utilizing innovative approaches to address the underlying causes and life-threatening diseases.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
January 09, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery Platform
Sponsor : Versant Ventures
Deal Size : $62.0 million
Deal Type : Series A Financing